Skip to main content
Premium Trial:

Request an Annual Quote

Vermillion Offering $16.4M in Common Stock

NEW YORK (GenomeWeb News) – Vermillion today announced a $16.4 million offering of common stock.

The Austin, Texas-based diagnostics firm is offering 8,350,000 shares of common stock at $1.96 per share. The company has also granted the underwriters a 30-day option to purchase up to an additional 1,252,500 shares to cover over-allotments. Net proceeds after deducting expenses are expected to be roughly $15.2 million.

The offering is expected to close on or about July 17.

Vermillion said it plans to use the proceeds to fund domestic and international commercialization efforts, enhancements to its bioinformatics platform, and an expansion of its portfolio.

Canaccord Genuity is acting as sole book-running manager, and Roth Capital Partners is acting as lead manager for the offering.

Vermillion stock was down 3 percent to $1.98 in morning trading on Nasdaq.

The Scan

ChatGPT Does As Well As Humans Answering Genetics Questions, Study Finds

Researchers in the European Journal of Human Genetics had ChatGPT answer genetics-related questions, finding it was about 68 percent accurate, but sometimes gave different answers to the same question.

Sequencing Analysis Examines Gene Regulatory Networks of Honeybee Soldier, Forager Brains

Researchers in Nature Ecology & Evolution find gene regulatory network differences between soldiers and foragers, suggesting bees can take on either role.

Analysis of Ashkenazi Jewish Cohort Uncovers New Genetic Loci Linked to Alzheimer's Disease

The study in Alzheimer's & Dementia highlighted known genes, but also novel ones with biological ties to Alzheimer's disease.

Tara Pacific Expedition Project Team Finds High Diversity Within Coral Reef Microbiome

In papers appearing in Nature Communications and elsewhere, the team reports on findings from the two-year excursion examining coral reefs.